Baig Mohammad Hassan, Ahmad Khurshid, Roy Sudeep, Ashraf Jalaluddin Mohammad, Adil Mohd, Siddiqui Mohammad Haris, Khan Saif, Kamal Mohammad Amjad, Provazník Ivo, Choi Inho
School of Biotechnology, Yeungnam University, Gyeongsan, 712749, Republic of Korea.
Curr Pharm Des. 2016;22(5):572-81. doi: 10.2174/1381612822666151125000550.
Over the last few decades, computer-aided drug design has emerged as a powerful technique playing a crucial role in the development of new drug molecules. Structure-based drug design and ligand-based drug design are two methods commonly used in computer-aided drug design. In this article, we discuss the theory behind both methods, as well as their successful applications and limitations. To accomplish this, we reviewed structure based and ligand based virtual screening processes. Molecular dynamics simulation, which has become one of the most influential tool for prediction of the conformation of small molecules and changes in their conformation within the biological target, has also been taken into account. Finally, we discuss the principles and concepts of molecular docking, pharmacophores and other methods used in computer-aided drug design.
在过去几十年中,计算机辅助药物设计已成为一种强大的技术,在新药分子的开发中发挥着关键作用。基于结构的药物设计和基于配体的药物设计是计算机辅助药物设计中常用的两种方法。在本文中,我们讨论了这两种方法背后的理论,以及它们的成功应用和局限性。为此,我们回顾了基于结构和基于配体的虚拟筛选过程。分子动力学模拟已成为预测小分子构象及其在生物靶标内构象变化最具影响力的工具之一,我们也对此进行了考虑。最后,我们讨论了计算机辅助药物设计中使用的分子对接、药效团和其他方法的原理和概念。